About BioAge Labs, Inc. (BIOA)
BioAge Labs, Inc. (BIOA) is a publicly traded company in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View real-time stock data, AI analysis, options flow, and convergence signals for BIOA on iGotFomo.
BIOA Key Statistics
| Current Price | $16.19 | Market Cap | $719 million |
|---|---|---|---|
| Daily Change | -8.99% | Volume | 270K |
| 52-Week High | $24.00 | 52-Week Low | $3.62 |
| P/E Ratio (TTM) | 1.18 | Forward P/E | -5.83 |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions About BIOA
- What is BioAge Labs, Inc. (BIOA)?
- BioAge Labs, Inc. (BIOA) is a publicly traded company in the Healthcare sector, operating in the Drug Manufacturers - Specialty & Generic industry.
- What is the current BIOA stock price?
- As of the latest trading session, BIOA trades at $16.19 per share, with a daily change of -8.99%.
- What is BIOA's market capitalization?
- BioAge Labs, Inc. has a market capitalization of $719 million, making it a small-cap stock.
- What sector does BIOA belong to?
- BioAge Labs, Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View all Healthcare stocks.